BA
EPZM

BlackRock Advisors’s Epizyme, Inc EPZM Stock Holding History

BlackRock Advisors’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$252K Sell
20,800
-444
-2% -$4.63K ﹤0.01% 2592
2016
Q3 		$209K Buy
21,244
+2,365
+13% +$21.6K ﹤0.01% 2668
2016
Q2 		$193K Sell
18,879
-58
-0.3% -$647 ﹤0.01% 2629
2016
Q1 		$230K Buy
18,937
+7,169
+61% +$72.5K ﹤0.01% 2490
2015
Q4 		$189K Sell
11,768
-5,667
-33% -$84K ﹤0.01% 2600
2015
Q3 		$224K Sell
17,435
-349
-2% -$7.04K ﹤0.01% 2661
2015
Q2 		$427K Sell
17,784
-32,895
-65% -$633K ﹤0.01% 2303
2015
Q1 		$952K Buy
50,679
+11,663
+30% +$241K ﹤0.01% 1592
2014
Q4 		$736K Buy
39,016
+32,504
+499% +$759K ﹤0.01% 1706
2014
Q3 		$177K Sell
6,512
-409,104
-98% -$12.7M ﹤0.01% 2695
2014
Q2 		$12.9M Buy
415,616
+15,461
+4% +$364K 0.01% 711
2014
Q1 		$9.11M Buy
400,155
+397,246
+13,656% +$12M 0.01% 819
2013
Q4 		$61K Sell
2,909
-57,136
-95% -$1.66M ﹤0.01% 3197
2013
Q3 		$2.4M Buy
60,045
+57,226
+2,030% +$1.94M ﹤0.01% 1124
2013
Q2 		$79K Buy
+2,819
New +$72.4K ﹤0.01% 3026

Other funds holding EPZM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

BlackRock Advisors's EPZM Position: Q4 2016 in Review

BlackRock Advisors reduced its Epizyme, Inc (EPZM) stake by 2.1% in Q4 2016, selling an estimated $4.63K and leaving 20,800 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #2592.

BlackRock Advisors first reported a position in EPZM in Q2 2013 and has held it in 15 quarters since. The position peaked at $12.9M in Q2 2014. 94 funds tracked by Wall St. Rank hold EPZM as of Q4 2016.

  • BlackRock Advisors held 20,800 shares of Epizyme, Inc worth $252K as of Q4 2016.
  • BlackRock Advisors sold 444 Epizyme, Inc shares in Q4 2016, an estimated $4.63K.
  • Epizyme, Inc made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2592 holding.
  • BlackRock Advisors first reported a position in Epizyme, Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Epizyme, Inc position peaked at $12.9M in Q2 2014.
  • 94 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.